MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cortical myoclonus (see myoclonus)"

  • 2025 International Congress

    Interpretable Video Analysis for Movement Disorders, A Case Study of Essential Tremor vs. Cortical Myoclonus

    R. Martínez-García-Peña, L. Koens, M. Tijssen, G. Azzopardi (Groningen, Netherlands)

    Objective: To demonstrate the feasibility of data-driven models for discovering interpretable movement features relevant to Essential Tremor (ET) vs Cortical Myoclonus (CM) diagnosis using video.…
  • 2025 International Congress

    Beyond “benign”, tremor and epilepsy in FAME3-A New Family Report with Progressive Course and Cognitive Impairment

    D. Campo-Caballero, F. Magrinelli, M. Carazo, M. Maneiro, A. Vinagre-Aragón, E. Mondragón, A. Gabilondo, J. Ruiz-Martínez, L. Blázquez, H. Houlden, P. Iruzubieta (San Sebastian, Spain)

    Objective: To report a family with Familial Cortical Myoclonic Tremor with Epilepsy(FAME) type 3 diagnosed through long-read sequencing and presenting a progressive disease course and…
  • 2025 International Congress

    Autosomal Dominant DHDDS-Related Movement Disorder Treated with Primidone

    D. Dewey, M. Khalaf, M. Hoerth, M. Osundiji, J. Caviness, S. Chiu (Scottsdale, USA)

    Objective: To describe novel clinical features and treatment response in a patient with neurodevelopmental disorder due to variants in dehydrodolichol diphosphate synthetase (DHDDS). Background: DHDDS…
  • 2025 International Congress

    The Genotypic and Phenotypic Spectrum of GOSR2 Mutations: Clinical and Pathophysiological Insights

    S. Polet, L. Siegal, S. Fuchs, M. Tijssen, T. de Koning (Groningen, Netherlands)

    Objective: Mutations in the GOSR2 gene are associated with North Sea-Progressive Myoclonus Epilepsy (NS-PME). Because more recently additional phenotypes have been described we systematically reviewed…
  • 2025 International Congress

    Phenotypical Study of Progressive Myoclonic Epilepsy in Eastern Algeria

    SM. Behloul, Y. Mecheri, A. Boulefkhad (Constantine, Algeria)

    Objective: We aim to analyze phenotypical features of individuals from eastern Algeria having a PME phenotype followed in our center (Dr Benbadis University Hospital). Background:…
  • 2024 International Congress

    Classification of Tremor and Myoclonus: An Explainable Machine Learning Approach

    E. vd Brandhof, I. Tuitert, A M. vd Stouwe, JW. Elting, J. Dalenberg, M. Biehl, M. Tijssen (Groningen, Netherlands)

    Objective: Providing a proof of concept for the classification of movement disorders using explainable machine learning applied to power spectra derived from accelerometry recordings. Background:…
  • 2024 International Congress

    Intermediate Expansion of MARCHF6 causes FAME3 without Epilepsy

    C. Del Gamba, E. Bieth, S. Kaya, E. Leitão, K. Astudillo, S. Frucht, C. Depienne, G. Riboldi (New York City, USA)

    Objective: To describe the first case of Familial adult myoclonic epilepsy 3 (FAME3) due to intermediate intronic expansion of MARCHF6. Background: FAME is an autosomal…
  • 2024 International Congress

    ‘If you can’t beat them, join them’: a patient and family perspective on quality of life with North Sea progressive myoclonus epilepsy

    SS. Polet, MMG. Bracke, MAJ. Tijssen, TJ. de Koning (Groningen, Netherlands)

    Objective: To describe the perspectives of patients and their family on quality of life (QoL) in North Sea- Progressive Myoclonus Epilepsy (NS-PME). Background: NS-PME is…
  • 2024 International Congress

    The Next Move in Movement Disorders: Differentiating between Hyperkinetic Movement Disorders using [18F] FDG PET

    J. Dalenberg, D. Peretti, L. Marapin, S. Jonker, E. Timmers, A. Vander Stouwe, M. Tijssen (Groningen, Netherlands)

    Objective: Understanding the differences in brain glucose metabolism between hyperkinetic movement disorders. Background: The Next Move in Movement Disorders (NEMO) study is a research initiative…
  • 2024 International Congress

    Deep Brain Stimulation for Post-Hypoxic Myoclonus: A Case Correlating Local Field Potentials to Clinical Outcome

    H. Kaur, T. Goble, A. Fenoy, R. Ramdhani (Great neck, USA)

    Objective: To correlate local filed potential (LFP) spectral data with clinical improvement of the Unified Myoclonus Rating Scale (UMRS) in post-hypoxic myoclonus (PHM) syndrome treated…
  • 1
  • 2
  • 3
  • 4
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley